SATB1 and epilepsy: This study aims to delineate the clinical and molecular characteristics of a novel de novo <i>SATB1</i> variant in a patient presenting with epilepsy-dominant NDDs phenotypes.<h4>Methods</h4>Triggered by the onset of seizures, trio-based whole-exome sequencing (Trio-WES) was performed to identify the genetic etiology.